|  | APRIL | miR-223 | miR-155 |
---|---|---|---|---|
APRIL | r |  | 0.29 | −0.05 |
P | Â | 0.038* | 0.76 | |
miR-223 | r | 0.29 | Â | 0.391 |
P | 0.038* | Â | 0.003* | |
miR-155 | r | −0.05 | 0.391 |  |
P | 0.76 | 0.003* | Â | |
ESR | r | 0.17 | 0.023 | 0.03 |
P | 0.27 | 0.88 | 0.87 | |
RF | r | 0.002 | −0.18 | 0.19 |
P | 0.98 | 0.26 | 0.22 | |
ANA | r | −0.04 | − 0.19 | − 0.43 |
P | 0.79 | 0.23 | 0.005* | |
VAS | r | 0.23 | 0.05 | −0.1 |
P | 0.06 | 0.76 | 0.55 | |
DAS28-CRP | r | 0.27 | 0.045 | −0.02 |
P | 0.02* | 0.78 | 0.89 | |
TJC | r | 0.2 | 0.03 | 0.05 |
P | 0.16 | 0.85 | 0.75 | |
SJC | r | 0.18 | 0.15 | 0.053 |
P | 0.25 | 0.33 | 0.74 | |
Disease duration | r | −0.07 | −0.12 | 0.02 |
P | 0.65 | 0.42 | 0.90 | |
MS by min | r | 0.12 | 0.07 | 0.05 |
P | 0.42 | 0.63 | 0.75 | |
Arthritis | r | 0.05 | −0.14 | 0.03 |
P | 0.75 | 0.37 | 0.85 | |
Deformities | r | 0.08 | 0.04 | −0.05 |
P | 0.6 | 0.82 | 0.77 | |
Fever | r | 0.23 | 0.23 | −0.12 |
P | 0.17 | 0.17 | 0.44 | |
Subcutaneous nodules | r | 0.005 | 0.39 | 0.21 |
P | 0.97 | 0.02* | 0.19 | |
Extra articular | r | 0.19 | 0.12 | −0.03 |
manifestations | P | 0.22 | 0.44 | 0.86 |